• Hero Banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Buying or Selling a Practice
Hospital Design
Leadership & Personal Growth
Personnel Management
Practice Finances
Practice Operations
Technology
Wellbeing & Lifestyle
Continuing Education
Conferences
Live Conferences
Conference News
Conference Proceedings
Resources
CBD in Pets
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

New treatment shows promise for treating heartworm disease

April 11, 2023
dvm360 Staff
dvm360, dvm360 April 2023, Volume 54, Issue 4
Pages: 18

An update for Heartworm Awareness Month

A recent study in Italy found that a combination of doxycycline and moxidectin for treating Dirofilaria immitis leads to a negative antigen status in dogs naturally infected with heartworm disease. Several formulations of moxidectin were evaluated and compared during the investigation.1

Spread through mosquito bites, heartworm disease can result in severe damage to the lungs, heart, and other organs in pets including dogs, cats, and ferrets. These parasites grow, mate, and reproduce while living inside a canine host.2

The FDA recommends prescription heartworm preventives approved by the agency as the best way to combat heartworm disease in dogs. The FDA has also approved injectable melarsomine dihydrochloride for killing adult heartworms in canines, and a topical combination of imidacloprid and moxidectin for ridding a dog’s bloodstream of microfilariae.2

Published in Parasites & Vectors, the new study aimed to evaluate the efficacy of 3 different formulations of moxidectin with doxycycline in 30 shelter dogs with heartworm disease. Divided into 3 groups of 10, the infected canines were treated with oral, topical, or injectable formulations of moxidectin. The oral and topical groups received moxidectin once a month for 9 consecutive months, whereas the injectable group received the drug at enrollment and again at 6 months. All groups received doxycycline for the first 30 days.1

Advertisement

Results of the study at day 270 showed 90% of dogs treated with oral moxidectin were antigen negative for D immitis. At day 270, 60% of canines with topical moxidectin and 80% of dogs treated with injectable formulation of the drug were also antigen negative. Additionally, investigators found all treatment groups showed radiographic improvement, nearly all of the studied dogs were cleared of pulmonary abnormalities, and 4 of these canines showed progressive improvement of cardiac function.1

In the United States, heartworm disease is commonly found along the Atlantic Ocean and Gulf of Mexico coastlines, as far north as New Jersey, as well as along the Mississippi River and its largest tributaries.2 However, the condition has been reported in all US states, and is endemic in many parts of the world.1,2

References

  1. Ciuca L, Vismarra A, Constanza D, et al. Efficacy of oral, topical and extended-release injectable formulations of moxidectin combined with doxycycline in Dirofilaria immitis naturally infected dogs. Parasit Vectors. Published online February 6, 2023. Accessed March 17, 2023. doi:10.1186/ s13071-023-05673-9
  2. Keep the worms out of your pet’s heart! The facts about heartworm disease. FDA. December 22, 2022. Accessed March 17, 2023. www.fda. gov/animal-veterinary/animal-health-literacykeep-worms-out-your-pets- heart-facts-about-heartworm-disease
download issueDownload Issue: dvm360 April 2023

Related Content:

dvm360 April 2023
“Vet shopping” is an alarming trend in opioid prescribing
“Vet shopping” is an alarming trend in opioid prescribing
dvm360® product report: Wellness supplements, plus gourmet peanut butter and more
dvm360® product report: Wellness supplements, plus gourmet peanut butter and more
Cardinal rules for building effective communication
Cardinal rules for building effective communication

Advertisement

Latest News

Drug for acute onset of canine pancreatitis is launched on the US market

New Automatic 2-in-1 Pet Feeder and Water Dispenser launched

PetHub launches AI tools for pet owners

Prairie dog pups emerge from underground at Maryland Zoo

View More Latest News
Advertisement